Skip to content

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy for the Anastomosis of Lacrimal Cyst Flap and Nasal Mucoperiosteal Flap

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06551766
Enrollment
20
Registered
2024-08-13
Start date
2023-03-01
Completion date
2024-12-31
Last updated
2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Dacryocystitis

Brief summary

To study the effect of Photosensitive hydrogel used for suture free anastomosis of lacrimal cyst and nasal mucoperiosteal flap in endoscopic nasal dacryocystostomy, and evaluate its adhesion to lacrimal cyst and nasal mucoperiosteal flap, promoting wound healing, forming a good anastomosis, preventing postoperative anastomosis and shortening operation time. Twenty patients with chronic dacryocystitis were randomly divided into photosensitive hydrogel group and suture group.Symptoms and nasal endoscopy were followed up 2, 6, and 12 weeks after surgery for both groups. And also adverse events were recorded at each follow-up.

Detailed description

After endoscopic dacryocystonasal anastomosis, granulation and/or cicatricial adhesion are the main reasons for surgical failure. How to achieve the ideal fit between the lacrimal sac flap and the nasal mucoperiosteal flap and avoid the proliferation of granulation and cicatricial adhesion is very important for the success of the operation. In this study, photocoupling reaction technology was used to achieve seamless integration and strong adhesion of photosensitive hydrogel materials to the wound, and the photohydrogel was applied to suture free adhesion and wound repair of the lacrimal cyst mucosal flap and nasal mucosal flap in endoscopic nasal Dacryocystostomy (En-DCR), and its feasibility, safety and effectiveness were evaluated.

Interventions

DEVICEPhotosensitive hydrogel

In the photosensitive hydrogel group, the anastomosis of the lacrimal cyst mucosal flap and the nasal mucoperiosteal flap was achieved by photosensitive hydrogel.

DEVICE6-0 absorbable stitches

In the suture fixation group, the anastomosis of the lacrimal cyst mucosal flap and the nasal mucoperiosteal flap was achieved by two stitches using 6-0 absorbable wire.

Sponsors

Eye & ENT Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Voluntarily participate in this clinical study and sign the informed consent; 2. Gender is not limited, age 18-75 years old; 3. The patient had symptoms and signs of chronic dacryocystitis, and the results of lacrimal passage irrigation suggested that the lower rush and return or upper rush and lower return, accompanied by mucous or purulent discharge reflux; 4. Lacrimal duct angiography suggests nasolacrimal duct obstruction without lacrimal canaliculi and/or duct obstruction.

Exclusion criteria

1. Age \< 18 or \> 75 years old; 2. Previous history of dacryocystonasal anastomosis; 3. Abnormal coagulation function; 4. Tumors of lacrimal passage, especially in patients with papilloma or malignant tumors; 5. in the acute dacryocystitis attack stage; 6. obvious scar constitution; 7. Complicated with serious nasal diseases, such as severe allergic rhinitis, chronic rhinosinusitis and nasal polyps, acute suppurative rhinosinusitis, severe atrophic rhinitis, and severe deviation of nasal septum; 8. Have serious heart, liver, kidney, lung and other basic diseases, can not tolerate general anesthesia; 9. Distance from the hospital, postoperative review is not convenient; 10. Participated in other clinical trials within the last 3 months; 11. Any medical history that the investigator determines may interfere with the test results or increase the patient's risk.

Design outcomes

Primary

MeasureTime frameDescription
Anastomotic opening rate6 weeks after surgeryThe opening of the anastomosis was observed by nasal endoscopy.

Secondary

MeasureTime frameDescription
Remission rate of tearing symptoms2, 6 and 12 weeks after surgeryThe remission of tearing symptoms was assessed by VAS scale

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026